Study of pharmacokinetics of gentamicin in rats under conditions of lymphotropic and intramuscular administration
Received: 2025-12-10 09:18:40
Published: 2026-02-27
Abstract
The study of the pharmacokinetics of antibiotics on model objects makes it possible to optimize their dosage and method of administration for further clinical practice.
Aim. The aim of this study was to compare the pharmacokinetics of gentamicin sulfate in rats following intramuscular and lymphotropic pretracheal administration.
Materials and methods. The disk diffusion method was used to determine the antibiotic concentration in blood and tissue homogenate for Escherichia coli NCTC 8172. Gentamicin sulfate concentration was highest in blood samples after intramuscular administration for the first hour and lowest in pleura. In the lymphotropic method, drug concentration in tissues was higher than after muscle injection, and most antibiotics accumulated in lung tissue within the first hour. Antibiotic kinetics were either linear or logarithmic.
Results. The results indicated that the highest concentration of gentamicin sulfate was found in blood samples after intramuscular administration for the first hour, while the least amount of antibiotics accumulated in the pleura. The kinetics of gentamicin were observed to be either linear or logarithmic. The half-life of the drug for lymphotropic administration was found to be 4 hours, while for intramuscular administration, it ranged from 2 to 5 hours, depending on the object of screening. After 24 hours, regardless of the method of administration, the antibiotic was eliminated at residual amounts of no more than 10 μg/mg.
Conclusion. The study concluded that the pretracheal method of administration is more effective and can be used to optimize gentamicin treatment of bacterial infections.
Keywords
List of references
-
Alavi M., Nokhodchi A. 2020. An overview of the antimicrobial and wound-healing properties of ZnO nanobiofilms, hydrogels, and bionanocomposites based on cellulose, chitosan, and alginate polymers. Carbohydrate Polymers, 227, 115349.
-
Asgarirad H., Ebrahimnejad P., Mahjoub M., Jalalian M., Morad H., Ataee R., Hosseini S.S., Farmoudeh A. 2021. A promising technology for wound healing: In vitro and in vivo evaluation of chitosan nano-biocomposite films containing gentamicin. Journal of Microencapsulation, 38(2), 100-107.
-
Asin-Prieto E., Rodrigues-Gascon A., Isla A. 2015. Applications of the pharmacokinetic/pharmacodynamics (PK/PD) analysis of antimicrobial agents. Journal of Infection and Chemotherapy, 21(5), 319-329.
-
Beganovic M., Luther M., Rice L., Arias, C.A., Rybak, M.J., LaPlante, K.L. 2018. A review of combination antimicrobial therapy for Enterococcus faecalis bloodstream infections and infective endocarditis. Clinical Infectious Diseases, 67(2), 303-309.
-
Chavaes B., Tadi P. 2022. Gentamicin. In: StatPearls. Treasure Island: StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK557550/
-
Dong M., Rodriguez A., Blankenship C., McPhail G., Vinks A.A., Hunter L.L. 2021. Pharmacokinetic modeling topredict risk of ototoxicity with intravenous tobramycin treatment in cystic fibrosis. Journal of Antimicrobial Chemotherapy, 76(11), 2923-2931.
-
Ferreira K., Forbes S., Kaski D. 2022. Vestibulotoxicity with gentamicin. BMJ, 7 (378), e070873.
-
Goutelle S., Woillard J.-B., Neely M., Yamada W., Bourguignon L. 2022. Nonparametric methods in population pharmacokinetics. The Journal of Clinical Pharmacology, 62(2), 142-157.
-
Guarch-Perez C., Shaqour B., Riool M., Verleije B., Beyers K., Vervaet C., Cos P., Zaat S.A.J. 2022. 3D-printed gentamicin-releasing poly-epsilon-caprolactone composite prevents fracture-related Staphylococcus aureus infection in mice. Pharmaceutics, 14, 1363.
-
Hathorn E., Dhasmana D., Duley L., Ross J.D.C. 2014. The effectiveness of gentamicin in the treatment of Neisseria gonorrhoeae: a systematic review. Systematic Reviews, 19(3), 104.
-
Hodiamont C., van den Broek A., Vroom S., Prins J.M., Mathôt R.A.A., van Hest R.M. 2022. Clinical pharmacokinetics of gentamicin in various patient populations and consequences for optimal dosing for gram-negative infections: an updated review. Clinical Pharmacokinetics, 61, 1075-1094.
-
Huck B., Thiyagarajan D., Bali A., Boese A., Besecke K.F.W., Hozsa C., Gieseler R.K., Furch M., Carvalho-Wodarz C., Waldow F., Schwudke D., Metelkina O., Titz A., Huwer H., Schwarzkopf K., Hoppstädter J., Kiemer A.K., Koch M., Loretz B., Lehr C.M. 2022. Nano-in-microparticles for aerosol delivery of antibiotic-loaded, fucose-derivated, and macrophage-targeted liposomes to combat mycobacterial infections: in vitro deposition, pulmonary barrier interactions, and targeted delivery. Advanced Healthcare Materials, 11, e2102117
-
Llanos-Paez C.C., Hennig S., Staatz C.E. 2017. Population pharmacokinetic modeling, Monte Carlo simulation and semi-mechanistic pharmacodynamic modeling as tools to personalize gentamicin therapy. Journal of Antimicrobial Chemotherapy, 72(3), 639-667
-
Mouton J.W., Muler A.E., Canton R., Giske C.G., Kahlmeter G., Turnidge J. 2018. MIC-based dose adjustment: facts and fables. Journal of Antimicrobial Chemotherapy, 73(3), 564-568.
-
Soh H.Y., Tan P.X.Y., Ng T.T.M., Chng H.T., Xie S. 2022. A critical review of the pharmacokinetics, pharmacodynamics and safety data of antibiotics in avian species. Antibiotics, 11(6), 741.
-
Sohail M.R., Garrigos Z.E., Elayi C.S., Xiang K., Catanzaro J.N. 2020. Preclinical evaluation of efficacy and pharmacokinetics of gentamicin containing extracellular-matrix envelope. Pacing and Clinical Electrophysiology, 43, 341-349.
-
Sörgel F., Höhl R., Glaser R., Stelzer C., Munz M., Vormittag M., Kinzig M., Bulitta J., Landersdorfer C., Junger A., Christ M., Wilhelm M., Holzgrabe U. 2017. Pharmacokinetics and pharmacodynamix of antibiotics in intensive care. Medizinische Klinik – Intensivmedizin und Notfallmedizin, 112(1), 11-23.
-
Steger L., Rinder M., Korbel R. 2020. Phenotypical antibiotic resistances of bacteriological isolates originating from pet, zoo, falconry birds. Tierärztliche Praxis Ausgabe K: Kleintiere / Heimtiere, 48, 260-269.
-
Tarakji K.G., Mittal S., Kennergren C., Corey R., Poole J.E., Schloss E., Gallastegui J., Pickett R.A., Evonich R., Philippon F., McComb J.M., Roark S.F., Sorrentino D., Sholevar D., Cronin E., Berman B., Riggio D., Biffi M., Khan H., Silver M.T., Collier J., Eldadah Z., Wright D.J., Lande J.D., Lexcen D.R., Cheng A., Wilkoff B.L. 2019. Antibacterial envelope to prevent cardiac implantable device infection. The New England Journal of Medicine, 381, 1782-1784
-
Wicha S.G., Märtson A.G., Nielsen E.I., Koch B.C.P., Friberg L.E., Alffenaar J.W., Minichmayr I.K., International Society of Anti-Infective Pharmacology (ISAP), the PK/PD study group of the European Society of Clinical Microbiology, Infectious Diseases (EPASG). 2021. From therapeutic drug monitoring to model-informed precision dosing for antibiotics. Clinical Pharmacology & Therapeutics, 109(4), 928-941.
-
Wilson K.E., Bogers S.H., Council-Troche R.M., Davis J.L. 2023. Potassium penicillin and gentamicin pharmacokinetics in healthy conscious and anesthetized horses. Veterinary Surgery, 52(1), 87-97.
About the Authors
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
